Principal Researcher, Prescription Drug Policy

About this role

Join AIR as a Principal Researcher, Prescription Drug Policy with our Healthcare Innovations team. This position leads complex CMS/CMMI prescription drug policy research, drives federal business development, and provides senior expertise on drug pricing and payment models to generate rigorous, actionable evidence for policymakers.

The Principal Researcher will report into AIR's Healthcare Innovations Team, which supports high-quality implementation and produces rigorous evidence on the effectiveness of new approaches to care and payment—translating findings into actionable insights for policymakers, payers, providers, and patients.

This position has the flexibility to work remotely within the United States (U.S.) or from one of AIR’s U.S. office locations. This does not include U.S. territories.

About AIR:

Founded in 1946 and headquartered in Arlington, Virginia, the American Institutes for Research (AIR) is a nonpartisan, not-for-profit organization that conducts behavioral and social science research and delivers technical assistance to address some of the most pressing challenges in the United States and globally. We generate evidence and apply data-driven solutions that expand opportunities and improve lives for all.

Responsibilities:

The responsibilities for the position include:

• Leads project and task execution and business development, specifically for work conducted for CMS and the CMS Innovation Center (CMMI).

• Directs execution of large complex projects or portfolio of smaller projects; oversees the planning, design, and implementation of project procedures.

• Provides senior subject matter expertise related to prescription drug prescribing, pricing, and rebate programs to delivery teams and/or proposal teams.

• Leads proposal efforts including review of proposals for sound practices and techniques, briefings, and client relation/development activities.

• Serves as industry expert for alternative payment models, value-based reimbursement, or Medicare payment policies, especially as they relate to prescription drug policies and pricing.

•